new version V2017

Veliparib poly ADP-ribose polymerase (PARP) inhibitor

ABT-888 - ABT888 - ABT 888 - 2-(2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide - 2-((R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide      

pdf
TrialStudied treatmentControl treatmentpatientsROBResultNCT

advanced breast cancer (metastatic)

NCT02163694 ongoing veliparib with carboplatin and caclitaxelPlacebo with Carboplatin and Paclitaxel - NCT02163694